POD-1 binding to the E-box sequence inhibits SF-1 and StAR expression in human adrenocortical tumor cells

Molecular and Cellular Endocrinology

Volumn 371, Issue 1-2, 2013, Pages 140-147

  França, Monica Malheiros ^a   Ferraz de Souza, Bruno ^a   Santos, Mariza Gerdulo ^a   Lerario, Antonio Marcondes ^a   Fragoso, Maria Candida Barisson Villares ^a   Latronico, Ana Claudia ^a   Kuick, Rork D ^b   Hammer, Gary D ^c   Lotfi, Claudimara F P ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF MICHIGAN COMPREHENSIVE CANCER CENTER   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

E box; Human adrenocortical tumor cells; NR5A1; POD 1; SF 1; TCF21

Indexed keywords

BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; COMPLEMENTARY DNA; HERPESVIRUS VECTOR; LUCIFERASE; MYC PROTEIN; PLASMID VECTOR; PROTEIN POD 1; STEROIDOGENIC ACUTE REGULATORY PROTEIN; STEROIDOGENIC FACTOR 1; UNCLASSIFIED DRUG;

ADRENAL CORTEX CARCINOMA; ADULT; ANIMAL CELL; CANCER GROWTH; CELL CYCLE PROGRESSION; CELL VIABILITY; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DOWN REGULATION; E BOX ELEMENT; EXPRESSION VECTOR; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE FREQUENCY; GENE REPRESSION; GENE TARGETING; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN DETERMINATION; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; REPORTER GENE; REVIEW; STEROIDOGENESIS; TRANSCRIPTION REGULATION; UPREGULATION;

ADRENAL CORTEX NEOPLASMS; ANIMALS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CELL LINE, TUMOR; CHROMATIN IMMUNOPRECIPITATION; E-BOX ELEMENTS; HUMANS; MICE; PHOSPHOPROTEINS; PROMOTER REGIONS, GENETIC; STEROIDOGENIC FACTOR 1; TRANSCRIPTION, GENETIC;

EID: 84876074711     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2012.12.029     Document Type: Review

References (31)

1. Almeida M.Q., Soares I.C., Ribeiro T.C., Fragoso M.C., Marins L.V., Wakamatsu A., Ressio R.A., Nishi M.Y., Jorge A.A., Lerario A.M., Alves V.A., Mendonça B.B., Latronico A.C. Steroidogenic factor-1 overexpression and gene amplification are more frequent in adrenocortical tumors from children than from adults. J. Clin. Endocrinol. Metab. 2010, 95:1458-1462.
2. Arab K., Smith L.T., Gast A., Weichenhan D., Huang J., Claus R., Hielscher T., Espinosa A.V., Ringel M.D., Morrison C.D., Schadendorf D., Kumar R., Plass C. Epigenetic deregulation of TCF21 inhibits metastasis suppressor KISS1 in metastatic melanoma. Carcinogenesis 2011, 32:1467-1473.
3. Cartharius K., Frech K., Grote K., Klocke B., Haltmeier M., Klingenhoff A., Frisch M., Bayerlein M., Werner T. MatInspector and beyond: promoter analysis based on transcription factor binding sites. Bioinformatics 2005, 21:2933-2942.
4. Cui S., Ross A., Stallings N., Parker K.L., Capel B., Quaggin S.E. Disrupted gonadogenesis and male-to-female sex reversal in Pod1 knockout mice. Development 2004, 131:4095-4105.
5. Daggett M.A., Rice D.A., Heckert L.L. Expression of steroidogenic factor 1 in the testis requires an E box and CCAAT box in its promoter proximal region. Biol. Reprod. 2000, 62:670-679.
6. de Reynies A., Assie G., Rickman D.S., Tissier F., Groussin L., Rene- Corail F., Dousset B., Bertagna X., Clauser E., Bertherat J. Gene expression profiling reveals a new classification of adrenocortical tumors and identifies molecular predictors of malignancy and survival. J. Clin. Oncol. 2009, 27:1108-1115.
7. Doghman M., Karpova T., Rodrigues G.A., Arhatte M., De Moura J., Cavalli L.R., Virolle V., Barbry P., Zambetti G.P., Figueiredo B.C., Heckert L.L., Lalli E. Increased steroidogenic factor-1 dosage triggers adrenocortical cell proliferation and cancer. Mol. Endocrinol. 2007, 21:2968-2987.
8. Figueiredo B.C., Cavalli L.R., Pianovski M.A., Lalli E., Sandrini R., Ribeiro R.C., Zambetti G., DeLacerda L., Rodrigues G.A., Haddad B.R. Amplification of the steroidogenic factor 1 gene in childhood adrenocortical tumors. J. Clin. Endocrinol. Metab. 2005, 90:615-619.
9. Fragoso M.C., Almeida M.Q., Mazzuco T.L., Mariani B.M., Brito L.P., Gonçalves T.C., Alencar G.A., Lima L de O., Faria A.M., Bourdeau I., Lucon A.M., Freire D.S., Latronico A.C., Mendonca B.B., Lacroix A., Lerario A.M. Combined expression of BUB1B, DLGAP5, and PINK1 as predictor of poor outcome in adrenocortical tumors: validation in a Brazilian cohort of adult and pediatric patients. Eur. J. Endocrinol. 2012, 166(1):61-67.
10. Funato N., Ohyama K., Kuroda T., Nakamura M. Basic helix-loop-helix transcription factor Epicardin/Capsulin/Pod-1 suppresses differentiation by negative regulation of transcription. J. Biol. Chem. 2003, 278:7486-7493.
11. Gazdar A.F., Oie H.K., Shackleton C.H., Chen T.R., Triche T.J., Myers C.E., Chrousos G.P., Brennan M.F., Stein C.A., La Rocca R.V. Establishment and characterization of a human adrenocortical carcinoma cell line that expresses multiple pathways of steroid biosynthesis. Cancer Res. 1990, 50:5488-5496.
12. Gicquel C., Raffin-Sanson M.L., Gaston V., Bertagna X., Plouin P.F., Schlumberger M., Louvel A., Luton J.P., Le Bouc Y. Structural and functional abnormalities at 11p15 are associated with the malignant phenotype in sporadic adrenocortical tumors: study on a series of 82 tumors. J. Clin. Endocrinol. Metab. 1997, 82:2559-2565.
13. Giordano T.J., Kuick R., Else T., Gauger P.G., Vinco M., Bauersfeld J., Sanders D., Thomas D.G., Doherty G., Hammer G. Molecular classification and prognostication of adrenocortical tumors by transcriptome profiling. Clin. Cancer Res. 2009, 15:668-676.
14. Heaton J.H., Wood M.A., Kim A.C., Lima L.O., Barlaskar F.M., Almeida M.Q., Fragoso M.C., Kuick R., Lerario A.M., Simon D.P., Soares I.C., Starnes E., Thomas D.G., Latronico A.C., Giordano T.J., Hammer G.D. Progression to adrenocortical tumorigenesis in mice and humans through insulin-like growth factor 2 and β-catenin. Am. J. Pathol. 2012, 181(3):1017-1033.
15. Hong C.Y., Gong E., Kim K., Suh J.H., Ko H., Lee H.J., Choi H., Lee K. Modulation of the expression and transactivation of androgen receptor by the basic helix-loop-helix transcription factor Pod-1 through recruitment of histone deacetylase1. Mol. Endocrinol. 2005, 19:2245-2257.
16. Kim A.C., Barlaskar F.M., Heaton J.H., Else T., Kelly V.R., Krill K.T., Scheys J.O., Simon D.P., Trovato A., Yang W.H., Hammer G.D. In search of adrenocortical stem and progenitor cells. Endocrinol. Rev. 2009, 30:241-263.
17. -ΔΔCt method. Methods 2001, 25:402-408.
18. Lu J., Richardson J.A., Olson E.N. Capsulin: a novel bHLH transcription factor expressed in epicardial progenitors and mesenchyme of visceral organs. Mech. Dev. 1998, 73:23-32.
19. Lu J., Chang P., Richardson J.A., Gan L., Weiler H., Olson E.N. The basic helix-loop-helix transcription factor capsulin controls spleen organogenesis. Proc. Natl. Acad. Sci. USA 2000, 97(17):9525-9530.
20. Luo X., Ikeda Y., Parker K.L. A cell-specific nuclear receptor is essential for adrenal and gonodal development and sexual differentiation. Cell 1994, 77:481-490.
21. Mather J.P. Establishment and characterization of two distinct mouse testicular epithelial cell lines. Biol. Reprod. 1980, 23:243-252.
22. Pianovski M.A., Cavalli L.R., Figueiredo B.C., Santos S.C., Doghman M., Ribeiro R.C., Oliveira A.G., Michalkiewicz E., Rodrigues G.A., Zambetti G., Haddad B.R., Lalli E. SF-1 overexpression in childhood adrenocortical tumours. Eur. J. Cancer 2006, 42:1040-1043.
23. Quaggin S.E. Trancriptional regulation of podocyte specification and differentitation. Microsc. Res. Tech. 2002, 57(4):208-211.
24. Quaggin S.E., Vanden Heuvel G.B., Igarashi P. Pod-1, a mesoderm-spcific basic-helix-loop-helix protein expressed in mesenchymal and glomerular epithelial cells in the developing kidney. Mech. Dev. 1998, 71:37-48.
25. Quaggin S.E., Schwartz L., Cui S., Igarashi P., Deimling J., Post M., Rossant J. The basic-helix-loop-helix protein Pod1 is critically important for kidney and lung organogenesis. Development 1999, 126. 5771-5583.
26. Robb L., Mifsud L., Hartley L., Biben C., Copeland N.G., Gilbert D.J., Jenkins N.A., Harvey R.P. Epicardin: a novel basic helix-loop-helix transcription factor gene expressed in epicardium, branchial arch myoblasts and mesenchyme of developing lung, gut, kidney and gonads. Dev. Dyn. 1998, 213:105-113.
27. Sbiera S., Schmull S., Assie G., Voelker H.U., Kraus L., Beyer M., Ragazzon B., Beuschlein F., Willenberg H.S., Hahner S., Saeger W., Bertherat J., Allolio B., Fassnacht M. High diagnostic and prognostic value of Steroidogenic factor-1 expression in adrenal tumors. J. Clin. Endocrinol. Metab. 2010, 95:E161-E171.
28. Smith L.T., Lin M., Brena R.M., Lang J.C., Schuller D.E., Otterson G.A., Morrison C.D., Smiraglia D.J., Plass C. Epigenetic regulation of the tumor suppressor gene TCF21 on 6q23-q24 in lung and head and neck cancer. PNAS 2006, 103:982-987.
29. Tamura M., Kanno Y., Chuma S., Saito T., Nakatsuji N. Pod-1/capsulin shows a sex- and stage-dependent expression pattern in the mouse gonad development and represses expression of Ad4BP/SF-1. Mech. Dev. 2001, 102:135-144.
30. Untergasser A., Nijveen H., Rao X., Bisseling T., Geurts R., Leunissen J.A.M. Primer3Plus, an enhanced web interface to Primer3. Nucleic Acids Res. 2007, 35:W71-74.
31. Yasumura Y.V., Buonassisi V., Sato G. Clonal analysis of differentiated function in animal cell cultures. I. Possible correlated maintenance of differentiated function and the diploid karyotype. Cancer Res. 1966, 26(3):529-535.